ZURAZura Bio Ltd
Earnings
When Zura Bio Ltd reports, what it reported each quarter, and how the stock took the results.
21 quarters. Jun 30, 2021 to Sep 30, 2026. mixed units.
Next results · Q4 2026Projected
Mar 18, before the open
Thu, Mar 18, 2027in 120 days
Projected from its last 8 releases. The company has not named the day yet.
- Quarter
- Q4 2026 · Ends about Dec 31, 2026
- 10-K window
- Mar 16 – Apr 14
Read against Q4 2025
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
- Revenue
- —
- Net income
- -$17.18M
- Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
- EPS
- —
- EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m
Latest results
- Revenue
- —
- —
- Net income
- -$25.83M
- N/M
- EPS
- -$0.20
- N/M
- Revenue
- —
- —
- Net income
- -$26.30M
- N/M
- EPS
- -$0.21
- N/M
- Revenue
- —
- —
- Net income
- -$24.22M
- N/M
- EPS
- -$0.22
- N/M
- Revenue
- —
- —
- Net income
- -$17.18M
- N/M
- EPS
- —
- —
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
| Q3 2026 | Sep 30, 2026 | Oct 27, 2026 · pre-market | Oct 27, 2026 | 27 d | 10-Q | — | — | -$0.20 | +19.9% | |
| Q2 2026 | Jun 30, 2026 | Aug 11, 2026 · pre-market | Aug 11, 2026 | 42 d | 10-Q | — | — | -$0.21 | 1.5% | |
| Q1 2026 | Mar 31, 2026 | May 7, 2026 · pre-market | May 7, 2026 | 37 d | 10-Q | — | — | -$0.22 | 7.8% | |
| FY 2025 | ||||||||||
| Q4 2025derived | Dec 31, 2025 | Mar 19, 2026 · after-hours | Mar 19, 2026 | 78 d | 10-K | — | — | — | 10.7% | |
| Q3 2025 | Sep 30, 2025 | Nov 13, 2025 · pre-market | Nov 13, 2025 | 44 d | 10-Q | — | — | -$0.21 | 10.0% | |
| Q2 2025 | Jun 30, 2025 | Aug 14, 2025 · pre-market | Aug 14, 2025 | 45 d | 10-Q | — | — | -$0.17 | +7.8% | |
| Q1 2025 | Mar 31, 2025 | May 8, 2025 · pre-market | May 8, 2025 | 38 d | 10-Q | — | — | -$0.19 | +2.9% | |
| FY 2024 | ||||||||||
| Q4 2024derived | Dec 31, 2024 | Mar 25, 2025 · pre-market | Mar 25, 2025 | 84 d | 10-K | — | — | — | +10.0% | |
| Q3 2024 | Sep 30, 2024 | Nov 7, 2024 · pre-market | Nov 7, 2024 | 38 d | 10-Q | — | — | -$0.26 | +4.0% | |
| Q2 2024 | Jun 30, 2024 | Aug 13, 2024 · pre-market | Aug 13, 2024 | 44 d | 10-Q | — | — | -$0.17 | 4.1% | |
| Q1 2024 | Mar 31, 2024 | May 9, 2024 · pre-market | May 9, 2024 | 39 d | 10-Q | — | — | -$0.02 | +1.7% | |
| FY 2023 | ||||||||||
| Q4 2023derived | Dec 31, 2023 | Mar 28, 2024 · pre-market | Mar 28, 2024 | 88 d | 10-K | — | — | — | +10.8% | |
| Q3 2023 | Sep 30, 2023 | — | Nov 13, 2023 | 44 d | 10-Q | — | — | -$0.18 | — | |
| Q2 2023 | Jun 30, 2023 | Aug 14, 2023 · after-hours | Aug 14, 2023 | 45 d | 10-Q | — | — | -$1.31 | — | |
| Q1 2023 | Mar 31, 2023 | — | May 12, 2023 | 42 d | 10-Q | — | — | -$2.76 | 12.3% | |
| FY 2022 | ||||||||||
| Q4 2022derived | Dec 31, 2022 | — | Mar 28, 2023 | 87 d | 10-K | — | — | — | +1.5% | |
| Q3 2022 | Sep 30, 2022 | — | Nov 14, 2022 | 45 d | 10-Q | — | — | -$2.87 | — | |
| Q2 2022 | Jun 30, 2022 | — | Aug 12, 2022 | 43 d | 10-Q | — | — | -$9.54 | — | |
| Q1 2022 | Mar 31, 2022 | — | May 13, 2022 | 43 d | 10-Q | — | — | -$72,395.48 | — | |
| FY 2021 | ||||||||||
| Q3 2021 | Sep 30, 2021 | — | Nov 19, 2021 | 50 d | 10-Q | — | — | — | — | |
| Q2 2021 | Jun 30, 2021 | — | Aug 27, 2021 | 58 d | 10-Q | — | — | -$0.02 | — | |
Earlier years, FY 2021 to FY 2023The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Source filings
Provenance
ProvenanceData status and checks
Zura Bio Ltd · CIK 1855644 · Engraved from SEC EDGAR